About BioNet Pharma
BioNet Pharma is a Healthcare company based in Munchen (Germany) founded in 2003. It develops and licenses pharmaceutical programs for various indications through partnerships. It operates on a B2B model. BioNet Pharma offers products and services including Development Programs. Its focus areas include Biotechnology, Drug Development, Clinical Programs and Therapeutics. Its legal entity is BioNet Pharma GmbH. Similar companies include Biogen, ADMA Biologics, Kymeratx, BioNTech and Generate Biomedicines and 5 more; 9 of its 10 listed similar companies have raised funding.
Company details
BioNet Pharma, based in Munich, Germany, originated from the Scil Group and focuses on pharmaceutical development. It handles projects that have advanced through preclinical and clinical phases, including phase II trials. The company engages in license deals with leading pharmaceutical firms for different indications, managed by executives like Christian Nafe. Its activities involve innovation in drug development, building on historical ties to entities like Boehringer Mannheim, and serving global partners in the industry.
- Headquarters Munchen, Germany
- SectorsHealthcare
- Email••••••••
- Website bionetpharma.com
- Legal Name Bionet Pharma Gmbh
Products & Services of BioNet Pharma
BioNet Pharma offers a comprehensive portfolio of products and services, including Development Programs.
Programs for preclinical and clinical phase drug advancements and licensing deals.
Similar companies to BioNet Pharma
BioNet Pharma has 10 listed similar companies in our database, 9 of them funded. They include Biogen, ADMA Biologics, Kymeratx, BioNTech and Generate Biomedicines, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| biogen.com | 1978 | Cambridge, United States | $80M | 1 | Therapies for neurodegenerative and immunology disorders are developed. | |
| admabiologics.com | 2005 | Ramsey, United States | $17.55M | 498 | Plasma-based biologics are developed for immune deficiency and infectious diseases. | |
| kymeratx.com | 2016 | Cambridge, United States | $197M | 150 | Small molecule protein degraders are developed for various disorders. | |
| biontech.com | 2008 | Mainz, Germany | $805.99M | 4,530 | Immunotherapeutics for cancer and other diseases are developed. | |
| generatebiomedicines.com | 2018 | Somerville, United States | $643M | 286 | Developer of novel protein-based therapeutics using machine learning and biological engineering | |
| puretechhealth.com | 2001 | Boston, United States | $107M | 171 | Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases. | |
| ucb.com | 1928 | Brussels, Belgium | – | 79 | Therapies for immunological and neurological disorders are developed. | |
| veratx.com | 2016 | San Francisco, United States | $196.58M | 46 | Therapeutic solutions for immunological and inflammatory diseases are developed. | |
| cabalettabio.com | 2017 | Radnor, United States | $88.26M | 60 | Developer of CAAR T cells for B cell-mediated autoimmune diseases | |
| apogeetherapeutics.com | 2022 | Waltham, United States | $149M | 91 | Developer of therapeutics for immunological and inflammatory disorders |
Detailed similar companies of BioNet Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Clinical Trials & Research Tech
10 companies that operate in the same segment as BioNet Pharma (Clinical Trials & Research Tech), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Genetic services are provided by Colossal's laboratory operations. | 2021 | Austin, Texas, United States | USD 617.6 M | – | 252 | |
Research lab engaged in pharmacological measurements on therapeutic protein variants | 2018 | United States | USD 78.19 M | – | 22 | |
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | 2004 | Ahmedabad, Gujarat, India | – | USD 50.52 M | 902 | |
Generic injectables for oncology and anesthesiology are manufactured. | 1989 | Hyderabad, Telangana, India | – | USD 4.22 M | 228 | |
Medical research labs are provided by GALY for scientific purposes. | 2018 | Boston, Massachusetts, United States | USD 61.59 M | – | 25 | |
Laboratory focused on biotechnology & molecule research services | 2018 | Cambridge, Massachusetts, United States | USD 32.68 M | – | – | |
Laboratory delivers discovery & research in nuclear and particle physics | 1947 | United States | – | – | 2,436 | |
Research and manufacturing of hemp products are conducted by BRC. | 2017 | Monterey, California, United States | USD 25.26 M | – | 16 | |
Genome sequencing studies are conducted for medical research purposes. | 2020 | Cambridge, Cambridgeshire, United Kingdom | USD 11.26 M | – | 12 | |
Novel immunotherapy therapeutic targets are discovered through laboratory research. | 2019 | Branford, Connecticut, United States | USD 92 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about BioNet Pharma
BioNet Pharma was founded in 2003.
BioNet Pharma is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
BioNet Pharma, based in Munich, Germany, originated from the Scil Group and focuses on pharmaceutical development. It handles projects that have advanced through preclinical and clinical phases, including phase II trials. The company engages in license deals with leading pharmaceutical firms for different indications, managed by executives like Christian Nafe. Its activities involve innovation in drug development, building on historical ties to entities like Boehringer Mannheim, and serving global partners in the industry.
BioNet Pharma's top competitors include ADMA Biologics, BioNTech and Vera Therapeutics.
BioNet Pharma offers Development Programs.
BioNet Pharma operates through Bionet Pharma Gmbh.